|
|
News Breaks | | | | January 31, 2013 | | 09:06 EDT |  | AGN, MAPP | Allergan commences tender offer for MAP Pharmaceuticals
Allergan (AGN)'s wholly-owned subsidiary, Groundhog Acquisition, has commenced a tender offer to purchase all outstanding shares of common stock of MAP Pharmaceuticals (MAPP) for $25.00 per share, net to the seller in cash, without interest and less any applicable withholding taxes. The board of directors of MAP has unanimously agreed to recommend that MAP’s stockholders accept the tender offer and tender their shares to Purchaser. The tender offer and withdrawal rights are scheduled to expire at 12:00 midnight, NYC time, on the night of February 28, unless extended. | |
|
News For AGN;MAPP From The Last 14 Days Check below for free stories on AGN;MAPP the last two weeks. |
|
|
| June 18, 2013 | | 09:04 EDT |  | AGN | Wells Faro to host a conference
2013 Healthcare Conference is being held in Boston on June 18-19 with webcasted company presentations to begin at 8:15 am; not all company presentations may be webcasted. Webcast Link | | | 08:36 EDT |  | AGN | Elan shares could be worh $19 in a buyout, says Jefferies
Jefferies raised its price target for shares of Elan (ELN) to $19 from $14, reflecting what it sees as the value of the company in a takeout scenario. The firm says Elan management suggested they would be open to sale in the $15-$20 per share range. Jefferies believes a high taxpaying suitor could pay the upper end of that range, and lists Allergan (AGN), Regeneron (REGN), Vertex (VRTX), Alexion (ALXN), Zoetis (ZTS), Mylan (MYL) and Perrigo (PRGO) as potential acquirers for Elan. Shares of Elan are up 13c to $13.62 in pre-market trading after Royalty Pharma announced that its buyout proposal for the company has expired. | | | 07:28 EDT | | AGN | Wells Faro to host a conference
 Subscribe for More Information | | | June 11, 2013 | | 13:09 EDT | | AGN | Allergan has a conference call hosted by BMO Capital
Subscribe for More Information | |
|
|
|
|
|
|
